About the Journal
Types or Articles
About CAR T Cells
Frequently Asked Questions (FAQ)
The Review
Contact Us
Search
Global Statistics
About the Journal
Types or Articles
About CAR T Cells
Frequently Asked Questions (FAQ)
The Review
Contact Us
Search
Stay on op - Get the daily news in your inbox
Subscribe
Latest Articles
Science
Eric Smith, and Andrew Aguirre Receive Michael F. Price Memorial Grant
Danielle Garcia
-
November 3, 2025
ASH
Orna Therapeutics to Present Study Results Supporting its in vivo CAR Programs for Autoimmune Diseases
Danielle Garcia
-
November 3, 2025
ASH
Recordati Rare Diseases to Share New Data at the American Society of Hematology (ASH) Meeting
Danielle Garcia
-
November 3, 2025
Clinical Trial Updates
CARsgen Announces Positive Clinical Data for Allogeneic CAR-T Products CT0596 and CT1190B
Danielle Garcia
-
November 3, 2025
Science
Human T Cell Leukopak Isolation Kit Successfully Utilized by LEAH Labs and the University of Missouri to Treat Canine Cancer
Danielle Garcia
-
October 29, 2025
News
2025 Merkin Prize in Biomedical Technology awarded to pioneers of CAR T-cell therapy
Danielle Garcia
-
October 29, 2025
Business & Economics
IASO Bio Partners with Korea’s GC Cell to Bring CAR-T Therapy to Korea
Danielle Garcia
-
October 29, 2025
Clinical Trial Updates
IASO Bio’s Anti-GPRC5D CAR T-Cell RD118 Shows Promising Results in Relapsed/Refractory Multiple Myeloma
Danielle Garcia
-
October 22, 2025
Conference Coverage
Lupus Foundation Showcases Research at 2025 Annual Meeting of the American College of Rheumatology
Danielle Garcia
-
October 21, 2025
Business & Economics
Liposarcoma: Increasing Awareness, Earlier Diagnosis and Expanding Pool of Treatable Patients Drives Market
Danielle Garcia
-
October 20, 2025
Conference Coverage
First-in-Human Phase I Trial of anti-CD20/BCMA Bispecific CAR-T Therapy in Patients with Refractory Autoimmune Diseases
Danielle Garcia
-
October 20, 2025
Conference Coverage
STAR-101 Study results Highlighted at the 17th International Mesothelioma Interest Group (iMig) 2025
Peter Hofland
-
October 2, 2025
1
2
3
4
Page 2 of 4